News | Balloon Catheter | May 22, 2017

Abbott Recalls 449,661 Coronary Balloon Catheters

Recall affects three Abbott balloon catheters due to difficulty removing balloon sheath

Abbott recalls its NC Balloon catheters

May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports of injury, and one report of death associated with difficulty removing the protective balloon sheath, resulting in issues with inflating or deflating the balloon. Abbott is recalling products from several identified lots because physicians may experience difficulty in removing the protective balloon sheath. This can result in issues with inflating or deflating the balloon during procedures and may cause serious adverse health consequences including air embolism, thrombosis, myocardial infarction and death.

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Abbott began contacting customers in March who received coronary catheters from the affected lots and is arranging the return and replacement of all remaining products. The total number of distributed units from identified lots potentially affected is 449,661. Global Health Authorities have been notified of the voluntary recall.

The recalled products include:
• Abbott NC Trek RX Coronary Dilatation Catheter

• Abbott NC Traveler Coronary Dilatation Catheter

• Abbott NC Tenku RX PTCA Balloon Catheter

Specific lots of affected product were manufactured between Jan. 1, 2015 – Jan. 2, 2017, and were distributed between Jan. 13, 2015 – March 14, 2017. Click on the specific catheter links above to see which lots were recalled.

Abbott said the specified balloons may exhibit difficulty in removing the protective balloon sheath, which can result in issues with inflating or deflating the balloon. The worldwide frequency of tight sheath removal, inflation and deflation reported events is 0.12 percent, the company said. In one reported case, failure to deflate the balloon necessitated surgery, leading to multiple post-operative complications and death.

Abbott said this recall does not affect patients having successfully undergone cardiac procedures using these devices. 

On March 22, 2017, Abbott sent a Field Safety Notice letter to healthcare providers and risk managers informing them of the device's risks, and corrective actions that would be implemented to ensure ongoing product performance. The letter asked providers and risk managers to immediately stop using the devices from the identified lots and remove or quarantine them. The vendor also said providers could contact Abbott Vascular to obtain a return authorization number to return all affected and unused products to the company.

Abbott also asked providers to acknowledge receipt of the notification by returning the "Effectiveness Check Form" provided by Abbott Vascular by email to: [email protected], or via fax at (951) 914-5951. 

Abbott's coronary dilatation catheters are indicated for use in balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis, coronary artery occlusion in patients with ST-segment elevation myocardial infarction (STEMI), and balloon dilatation of a stent after implantation (2-5 mm balloon models only).

Customers with questions may contact their local Abbott Vascular representative, or contact Abbott's customer service department at (800) 227-9902.

For more information:

Related Content

Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score Percutaneous Transluminal Angioplasty (PTA) Scoring Sheath platform for use in iliac, ilio-femoral, popliteal, infra-popliteal and renal arterial plus synthetic and/or native arteriovenous hemodialysis fistula. This is a new type of scoring balloon technology.
News | Balloon Catheter | June 04, 2020
June 4, 2020 — Transit Scientific announced the U.S.
NC Trek RX Coronary Dilatation Catheter is part of an FDA Class I recall because it may not defalte.
News | Balloon Catheter | February 24, 2020
February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters
Edwards Lifesciences Recalls IntraClude Intra-aortic Occlusion Device
News | Balloon Catheter | July 15, 2019
Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon rupture during...
Gore Molding & Occlusion Balloon for Endovascular Aortic Repair Receives FDA Approval
Technology | Balloon Catheter | August 23, 2018
W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Gore...
Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni